Orano Med is at the forefront of research in nuclear medicine and is developing new therapies against cancer. Based on its unique expertise in the production of lead-212 (Pb-212) and radiolabeling technologies, Orano Med is developing innovative radioligand therapies which consist of selectively destroying cancer cells while limiting the impact on surrounding healthy cells.
With a solid portfolio of molecules in development capable of targeting various forms of cancer, and a reliable supply chain for Pb-212, Orano Med aims to become a leader in targeted alpha therapies, in particular for patients with currently unmet medical needs.
Orano Med seeks to develop a new generation of targeted therapies against cancer using the unique properties of lead-212 (212Pb), a rare alpha-emitting radioisotope and one of the most potent therapeutic payloads against cancer cells. Orano Med is a biotech company located in France and in the US (Plano, TX, and Brownsburg, IN). With several treatments currently at the clinical stage, Orano Med is a fast-growing R&D and industrial company.
Orano Med LLC is currently looking for a Chief Accountant to manage and develop the Finance activities and support the growth of the US-based companies. This position reports directly to the CFO of Orano Med SAS located in France.
All candidates must meet the following minimum requirements in order to be considered for this opportunity. Candidates who exceed minimum qualifications may be considered for a higher level position.
Education and Experience: